BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33881561)

  • 1. Endogenous cortisol excess confers a unique lipid signature and metabolic network.
    Vega-Beyhart A; Iruarrizaga M; Pané A; García-Eguren G; Giró O; Boswell L; Aranda G; Flores V; Casals G; Alonso C; Mora M; Halperin I; Carmona F; Enseñat J; Vidal O; Hu T; Rojo G; Gomis R; Hanzu FA
    J Mol Med (Berl); 2021 Aug; 99(8):1085-1099. PubMed ID: 33881561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue.
    Aragón-Herrera A; Feijóo-Bandín S; Abella V; Álvarez L; Roselló-Lletí E; Portolés M; Tarazón E; Bigazzi M; Bani D; Gualillo O; González-Juanatey JR; Lago F
    Pharmacol Res; 2019 Jun; 144():51-65. PubMed ID: 30954631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome.
    Vega-Beyhart A; Laguna-Moreno J; Díaz-Catalán D; Boswell L; Mora M; Halperin I; Casals G; Hanzu FA
    Front Endocrinol (Lausanne); 2022; 13():833644. PubMed ID: 35282465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic maternal cortisol excess during late gestation leads to metabolic alterations in the newborn heart.
    Walejko JM; Antolic A; Koelmel JP; Garrett TJ; Edison AS; Keller-Wood M
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E546-E556. PubMed ID: 30620638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.
    Kotłowska A; Puzyn T; Sworczak K; Stepnowski P; Szefer P
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
    Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
    Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography-quadrupole time of flight electrospray in a positive ionization mode mass spectrometry.
    Vonica CL; Ilie IR; Socaciu C; Moraru C; Georgescu B; Farcaş A; Roman G; Mureşan AA; Georgescu CE
    Scand J Clin Lab Invest; 2019 Oct; 79(6):437-442. PubMed ID: 31462125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of a newly developed salivary cortisol and cortisone measurement using an LC-MS/MS method with simple and rapid sample preparation.
    Mészáros K; Karvaly G; Márta Z; Magda B; Tőke J; Szücs N; Tóth M; Rácz K; Patócs A
    J Endocrinol Invest; 2018 Mar; 41(3):315-323. PubMed ID: 28815484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Untargeted Metabolomics Analysis of the Serum Metabolic Signature of Childhood Obesity.
    Szczerbinski L; Wojciechowska G; Olichwier A; Taylor MA; Puchta U; Konopka P; Paszko A; Citko A; Goscik J; Fiehn O; Fan S; Wasilewska A; Taranta-Janusz K; Kretowski A
    Nutrients; 2022 Jan; 14(1):. PubMed ID: 35011090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics and correlation network analyses of core biomarkers in type 2 diabetes.
    Lin W; Wang M; Chen M; Zheng X; Wu Y; Gao D; Yang Z; Tian Z
    Amino Acids; 2020 Sep; 52(9):1307-1317. PubMed ID: 32930872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.
    Guarnotta V; Amato MC; Pivonello R; Arnaldi G; Ciresi A; Trementino L; Citarrella R; Iacuaniello D; Michetti G; Simeoli C; Colao A; Giordano C
    Endocrine; 2017 Feb; 55(2):564-572. PubMed ID: 26965912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipose tissue in cortisol excess: What Cushing's syndrome can teach us?
    Bavaresco A; Mazzeo P; Lazzara M; Barbot M
    Biochem Pharmacol; 2024 May; 223():116137. PubMed ID: 38494065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and Local Metabolic Alterations in Sleep-Deprivation-Induced Stress: A Multiplatform Mass-Spectrometry-Based Lipidomics and Metabolomics Approach.
    Yoon SJ; Long NP; Jung KH; Kim HM; Hong YJ; Fang Z; Kim SJ; Kim TJ; Anh NH; Hong SS; Kwon SW
    J Proteome Res; 2019 Sep; 18(9):3295-3304. PubMed ID: 31313932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics and Lipidomics Profiling Reveals Hypocholesterolemic and Hypolipidemic Effects of Arabinoxylan on Type 2 Diabetic Rats.
    Nie Q; Xing M; Chen H; Hu J; Nie S
    J Agric Food Chem; 2019 Sep; 67(38):10614-10623. PubMed ID: 31483658
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.